• Central angiotensinergic and cholinergic mechanisms have important role in the cardiovascular regulation.
Introduction
Important mechanisms involved in the control of cardiovascular function like those that affect vasopressin secretion and sympathetic activity are present in the forebrain and in the hindbrain [10, 11, 34] . The basic control of the cardiovascular function depends on a medullary circuitry involving the nucleus of the solitary tract (NTS), the nucleus ambiguus (NA) and the ventrolateral medulla (caudal and rostral) that controls the autonomic discharges to the cardiovascular system [23, 37] . Although the activity of the medullary circuitry is controlled mainly by signals that arise from the peripheral cardiovascular receptors, especially baroreceptors and chemoreceptors, descending signals from different encephalic areas, particularly from forebrain areas, might also influence the activity of medullary circuitry and the discharge of the autonomic projections to the cardiovascular system, allowing more complex cardiovascular adjustments [28] .
Among the forebrain areas involved in the control of the cardiovascular function and fluid/electrolyte balance, several studies have shown the importance of the tissue surrounding the anteroventral third ventricle (AV3V region) [7, 10, 11, 28, 32] . The AV3V region includes the organ vasculosum of lamina terminalis, an area lacking blood-brain barrier and rich in angiotensin II (ANG II) receptors, the ventral part of the median preoptic nucleus and the periventricular preoptic area. Electrolytic lesions of the AV3V region impair the development of some models of experimental hypertension and abolish the pressor responses to intracerebroventricular (i.c.v.) administration of ANG II or the cholinergic agonist carbachol [10, 11, 14, 15, 32, 33] . Moreover, lesions of the AV3V region reduce vasopressin secretion and increase baroreflex sensitivity to ANG II without changing the baroreflex responses to intravenous phenylephrine and sodium nitroprusside [7, 10, 11, 28, 32, 39] .
The RVLM, located ventrally to the NA, is a main central site that activates sympathetic pre-ganglionic neurons in the spinal cord [3, 13, 16, 17, 22, 23, 35, 38] . The activity of the RVLM is influenced by inhibitory signals from baroreceptors and excitatory signals from chemoreceptors and from forebrain areas like the paraventricular nucleus of the hypothalamus [1, 21, 24, 34] . The amino acid GLU, ANG II and acetylcholine are important excitatory neurotransmitters in the RVLM [3, 5, 8, 18, 26, 31, 38] .
A previous study showed that the pressor responses produced by GLU injected into the RVLM in unanesthetized rats are reduced by acute or chronic lesions of the AV3V region, suggesting a facilitatory role of the AV3V region for the activation of pressor mechanisms by glutamatergic activation in the RVLM [42] . Similar to the injection of GLU, injections of ANG II or carbachol into the RVLM also increase sympathetic activity and MAP [5, 30, 40, 44] . Therefore, in the present study, we investigated the effects of the AV3V lesions in the pressor responses produced by the injection of ANG II or carbachol into the RVLM in unanesthetized rats.
Materials and methods

Animals
Male Holtzman rats (280-320 g) were used. The animals were housed individually in stainless steel cages in a room with controlled temperature (23 ± 2 • C) and humidity (55 ± 10%). Lights were on from 7:00 am to 7:00 pm. Guabi rat chow and tap water were available ad libitum. The Ethical Committee for Animal Care and Use from Dentistry School of Araraquara approved the experimental protocols.
Electrolytic AV3V lesion
Rats were anesthetized with ketamine (80 mg/kg of body weight) plus xylazine (7 mg/kg of body weight) and placed in a two-arm stereotaxic frame (model 900, David Kopf Instruments). A tungsten wire electrode (0.4 mm in diameter) bared at the tip (0.5 mm) was inserted into the brain using the coordinates: 0.0 mm from bregma, in the midline and 7.0 mm below dura mater. Electrolytic lesions were performed using a cathode current (2 mA for 10 s). Sham lesioned rats had the electrode placed along the same coordinates, except that no current was passed.
Implant of cannulas in the RVLM
Immediately after AV3V lesions, a stainless steel cannula (10 × 0.6 mm o.d.) was implanted into the RVLM using the coordinates 3.7 mm caudal to lambda, 1.9 mm lateral to midline and 7.0 mm below dura mater. The cannula was fixed to the cranium using dental acrylic resin and jeweler screws.
At the end of the surgery, the rats received an intramuscular penicillin injection (30,000 IU) and a subcutaneous injection of the analgesic ketoprofen 1%. The rats were maintained individually in cages with free access to water, food pellets and 10% sucrose to prevent the dehydration due the acute adipsia caused by the AV3V lesion.
Arterial pressure and heart rate recordings
Mean arterial pressure (MAP) and heart rate (HR) were recorded in unanesthetized rats. On the day before the recording, rats were anesthetized with ip ketamine + xylazine and a polyethylene tubing was inserted into the abdominal aorta through the femoral artery for MAP and HR recordings. The catheter was tunneled subcutaneously and exposed on the back of the rat to allow access in unrestrained, freely moving rats. For the recordings, the arterial catheter was connected to a pressure transducer coupled to a preamplifier connected to a Powerlab data acquisition system (16SP, ADInstruments).
Injection into the RVLM
Injections into the RVLM were performed using 5-l Hamilton syringes connected by polyethylene tubing to the injector needle (1.5 mm longer than the guide cannula). The injection volume was 100 nl.
Histology
At the end of the experiments, 2% Evans blue solution (100 nl) was injected into the RVLM. The animals were deeply anesthetized with sodium thiopental (70 mg/kg, ip). Saline followed by 10% buffered formalin was perfused through the heart. The brains were frozen, cut coronally (50 m sections), stained with Giemsa stain and analyzed by light microscopy to confirm the injections into the RVLM and the site of AV3V lesion.
Statistical analysis
The results are reported as means ± standard error of means (SEM). Two way repeated measure ANOVA and Newman Keuls tests were used for comparisons. Differences were considered significant at p < 0.05.
Experimental protocols
One day after the implant of the catheters, the arterial catheter was connected to the pressure transducer. About 20 min after starting the recording, saline was injected into the RVLM. Twenty minutes later, ANG II (200 ng/100 nl) was injected into the RVLM and MAP and HR were recorded during 30 min. Six hour later, the same procedure was repeated and carbachol (1 nmol/100 nl) was injected into the RVLM instead of ANG II.
Baseline MAP and HR and the maximum change (peak change) of MAP and HR produced by the injections were analyzed. Baseline MAP and HR represents the average of the last 5 min before injection into the RVLM. The maximum changes were calculated from a steady state just before the injection.
Results
Histological analysis
Injections into the RVLM were ventral to the NA (approximately 200-400 m caudal to the facial nucleus). The AV3V lesions were located between the anterior commissure and the floor of the third ventricle with bilateral periventricular damage from the lamina terminal is to the preoptic area and anterior hypothalamus, never extending caudally to the arcuate nucleus or laterally to the medial hypothalamus (Fig. 1) . A total of 70 rats were used (38 submitted to AV3V lesions and 32 with sham lesions, all of them with RVLM cannula).
Cardiovascular responses to ANG II or carbachol injected into the RVLM in AV3V lesioned rat
Baseline MAP was not modified by the acute or chronic AV3V lesion. Injections of ANG II or carbachol into the RVLM induced pressor responses in acute or chronic sham lesioned rats (Figs. 2 and 3) . Acute or chronic AV3V lesions reduced the pressor responses to ANG II injected into the RVLM, without changing carbachol-induced pressor responses (Figs. 2 and 3) . ANOVA showed significant interaction between acute groups and drugs [F(2,22) = 6.31; p < 0.05] and significant difference between chronic groups [F(1,13) = 5.14; p < 0.05]. Incomplete AV3V lesions did not affect the pressor response to ANG II injected into the RVLM and injections of ANG II or carbachol outside the RVLM did not significantly change MAP or HR.
Acute AV3V lesions increased the baseline HR, whereas chronic AV3V lesions did not affect baseline HR. Injections of ANG II or carbachol into the RVLM produced no significant change in HR in acute or chronic sham-or AV3V-lesioned rats (Figs. 2 and 3 ).
Discussion
Previous results showed that acute or chronic lesions of the AV3V region attenuated the pressor response produced by the injection of GLU into the RVLM [42] . The present results show that acute or chronic AV3V lesions also affect the pressor response to ANG II injected into the RVLM in unanesthetized rats. Therefore the present and the previous results suggest that facilitatory mechanisms from the AV3V region are important for the pressor response to glutamatergic or angiotensinergic activation of the RVLM. Moreover, they suggest that the AV3V mechanisms are important for the pressor responses produced by the action of specific neurotransmitters in the RVLM.
Central angiotensinergic and cholinergic mechanisms have important roles in the cardiovascular regulation [8, 9, 19, 31, 33, 43, 44] . Acetylcholine and ANG II receptors are present in the RVLM [2, 4, 27, 29] and the activation of these receptors increases sympathetic activity and MAP [6, 20, 25, 29, 34, 36] . Although similar pressor mechanisms seem to be activated by angiotensinergic or cholinergic stimulation in the RVLM, AV3V lesions reduced the pressor response to ANG II without changing the response to carbachol injected into the RVLM. These results are similar to those of a previous study showing that acute or chronic AV3V lesions block the pressor response to GLU [41] , but not to substance P, injected into the NTS. Therefore, there are specific hindbrain pressor mechanisms that depend on facilitatory signals from the AV3V region to be completely activated. Importantly, the AV3V lesions impair the development of many forms of experimental hypertension in rats and, therefore, the reduced action of angiotensinergic and glutamatergic pressor mechanisms in the RVLM might play a role in the anti-hypertensive effect of the AV3V lesion [10, 11] . Interestingly, injection of the AT1 receptor antagonists losartan or ZD 7155 into the RVLM reduced the pressor response to GLU injected into the same area, which suggests an interaction between angiotensinergic and glutamatergic pressor mechanisms in the RVLM [44] . This interaction might explain why AV3V lesions affect the pressor response to GLU and ANG II injected into the RVLM.
Increases in HR and slight or no increase in MAP have been reported in the first days after AV3V lesions [32] . Additionally, previous studies have shown that the cardiovascular responses produced by chemoreflex or baroreflex activation are not modified by acute or chronic AV3V lesions [41, 42] . Therefore, the effects produced by AV3V lesion on the pressor responses to ANG II into the RVLM are not due to any change on baseline MAP or any impairment of baro or chemoreflex responses. Although the AV3V lesions produce transitory adipsia (in the first 5-7 days) and chronic hypernatremia [10, 11] , these changes in fluid electrolyte balance are probably not the cause of the reduction in the pressor responses to ANG II. Acute and chronic AV3V lesions reduced the pressor response to injections of ANG II into the RVLM, whereas adipsia was present only acutely and hypernatremia is suggested to increase the pressor response to the activation of the RVLM, instead of reducing it [12] . In addition, the AV3V lesions impaired the pressor response to ANG II, but not to carbachol, into the RVLM which suggests that there are specific pressor mechanisms in the RVLM modified by the AV3V lesions.
In spite of the importance of the medullary circuitry that includes the RVLM for the cardiovascular control, the AV3V region has been shown to play important role in the control of pressor responses that depend on sympathetic activation [10, 11, 41] . Lesions of the AV3V region reduce arterial pressure in different models of experimental hypertension, the pressor responses to i.c.v. injections of ANG II or the cholinergic agonist carbachol, or to injections of GLU into the RVLM or the NTS, which suggests that important pressor mechanisms activated in these conditions are under the control of the AV3V region [10, 11, 14, 15, 32, 33, 39, 41] . Neurons from the RVLM directly activate pre-motor sympathetic fibers in the intermediolateral column in the spinal cord (IML) [13, 17, 24] and, therefore, the activation of the RVLM neurons with ANG II is expected to directly activate sympathetic mechanisms that produce pressor responses. However, the present results suggest that the AV3V lesions reduce the sympathetic activation produced by ANG II injected into the RVLM. The mechanisms involved in these effects of the AV3V lesions are not clear. One possibility is the reduction of the excitability of the RVLM neurons that are activated by ANG II, which results in reduced sympathetic activation. The reduction in the neuronal excitability of the RVLM neurons might be caused by the reduction of facilitatory signals or the increase of inhibitory signals to the RVLM. The RVLM receives inhibitory and excitatory influences from different hindbrain and forebrain areas [1, 16, 17, 24] . As suggested by a previous study [42] , the AV3V lesions may produce an imbalance in those influences, by either reducing facilitatory or increasing inhibitory signals, or both, to the RVLM, thus reducing the excitability of RVLM neurons involved in sympathetic activation produced by glutamatergic or angiotensinergic mechanisms. The neuronal activity of the RVLM is facilitated by central angiotensinergic mechanisms [17] and the AV3V lesions reduce the release of excitatory signals from the forebrain angiotensinergic mechanisms to increase sympathetic activity [10, 11, 28] , which may reduce the excitability of the RVLM neurons. Although the decrease in the RVLM excitability is a possible mechanism, AV3V lesions might also reduce pressor responses by directly changing the excitability of sympathetic neurons in the IML.
In conclusion, the present study demonstrated that the integrity of the AV3V region is necessary for the full expression of the pressor response induced by angiotensin II injected into the RVLM. This suggests that the AV3V region modulates the excitability of the RVLM neurons involved with the pressor response produced by the activation of angiotensinergic mechanisms in this area.
